Which of the following is NOT a TNF alpha inhibitor?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Prepare for the CMS II Rheumatology E1 Exam. Enhance your skills with engaging flashcards, detailed explanations, and multiple-choice questions. Get exam-ready today!

Multiple Choice

Which of the following is NOT a TNF alpha inhibitor?

Explanation:
TNF-alpha inhibitors work by blocking the activity of tumor necrosis factor-alpha, a key driver of inflammation. Infliximab and adalimumab are antibodies that bind TNF-alpha, preventing it from signaling. Etanercept is a fusion protein that acts as a decoy receptor, sequestering TNF-alpha (and TNF-beta) away from its receptors. Tocilizumab, on the other hand, targets the IL-6 receptor, blocking IL-6 signaling rather than TNF-alpha. Therefore, tocilizumab is not a TNF-alpha inhibitor.

TNF-alpha inhibitors work by blocking the activity of tumor necrosis factor-alpha, a key driver of inflammation. Infliximab and adalimumab are antibodies that bind TNF-alpha, preventing it from signaling. Etanercept is a fusion protein that acts as a decoy receptor, sequestering TNF-alpha (and TNF-beta) away from its receptors. Tocilizumab, on the other hand, targets the IL-6 receptor, blocking IL-6 signaling rather than TNF-alpha. Therefore, tocilizumab is not a TNF-alpha inhibitor.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy